KASINGER JAMES R. bought CRSP
February 18, 2026 · Form 4 insider transaction
KASINGER JAMES R. bought 3,825 shares of CRISPR Therapeutics AG, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,825
Price
N/A
Total value
N/A
InsiderKASINGER JAMES R.
RoleOfficer
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateFebruary 18, 2026
Filing dateFebruary 20, 2026
Shares owned after87,227
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.